Add Formweb to your mobile device
Search results for:
denosumab
denosumab
- Restricted: denosumab is restricted to use in the Outpatient setting
Brand names: Aukelso, Bildyos Prefilled Syringe, Bilprevda, Bomyntra, Bomyntra Prefilled Syringe, Bosaya Prefilled Syringe, Conexxence Prefilled Syringe, Enoby Prefilled Syringe, Jubbonti Prefilled Syringe, Osenvelt, Ospomyv Prefilled Syringe, Prolia, Stoboclo Prefilled Syringe, Wyost, Xgeva, Xtrenbo
| Form | Strength | ANAN | ASMP | LACH | LALK | LOHH | LOLR | LOWC | SDSD | SESE | SFSF | Formulary Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SOLUTION, SUBCUTANEOUS | 60 mg/mL; 120 mg/1.7 mL; bbdz 60 mg/mL; bbdz 120 mg/1.7 mL; bmwo 60 mg/mL; bmwo 120 mg/1.7 mL; bnht 60 mg/mL; bnht 120 mg/1.7 mL; dssb 60 mg/mL; kyqq 60 mg/mL; kyqq 120 mg/1.7 mL; nxxp 60 mg/mL; nxxp 120 mg/1.7 mL; qbde 60 mg/mL; qbde 120 mg/1.7 mL | restricted to outpatient use only |
VIEW MORE Bone-modifying Agents, Bone Resorption Inhibitors
Last updated: May. 28, 2026
- Black Box Warning: Severe Hypocalcemia in Patients with Advanced Kidney Disease and Severe Hypocalcemia and Mineral Metabolism Changes
- Therapeutic Interchange: Biosimilar and Reference Products Conversion List for Adults
Chemotherapy Chart
Medication
Reference Drug or Biosimilar
Formulary Status
Automatic Therapeutic Interchange
Inpatient1
Outpatient
*New Starts/New Authorizations Only*
Wyost (denosumab-bbdz)
Biosimilar
Formulary, restricted to OP (preferred)
NFT approval is needed
Use Wyost unless third party payer requires other denosumab product
Xgeva (denosumab)
Reference
Formulary, restricted to OP
(not preferred)
Interchange to Wyost unless third party payer requires other denosumab product
Osenvelt (denosumab-bmwo)
Bomyntra (denosumab-bnht)
Xbryk (denosumab-dssb)
Bilprevda (denosumab-nxxp)
Aukelso (denosumab-kyqq)
Xtrenbo (denosumab-qbde)
Oziltus (denosumab-mobz)
Jubereq (denosumab-desu)
Biosimilars
Medication
Reference Drug or Biosimilar
Formulary Status
Automatic Therapeutic Interchange
Inpatient1
Outpatient
*New Starts/New Authorizations Only*
Jubbonti (denosumab-bbdz)
Biosimilar
Formulary, restricted to OP (preferred)
NFT approval is needed
Use Jubbonti unless third party payer requires other denosumab product
Prolia (denosumab)
Reference
Formulary, restricted to OP
(not preferred)
Interchange to Jubbonti unless third party payer requires other denosumab product
Stoboclo (denosumab-bmwo)
Conexxence (denosumab-bnht)
Ospomyv (denosumab-dssb)
Bildyos (denosumab-nxxp)
Bosaya (denosumab-kyqq)
Enoby (denosumab-qbde)
Boncresa (denosumab-mobz)
Osvyrti (denosumab-desu)
Biosimilars